Trial Profile
Economic assessment of gemifloxacin for the management of acute exacerbations of chronic bronchitis in Mexico.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2013
Price :
$35
*
At a glance
- Drugs Gemifloxacin (Primary) ; Ceftriaxone; Cefuroxime; Clarithromycin; Levofloxacin; Moxifloxacin
- Indications Acute exacerbations of chronic bronchitis; Bacterial infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 May 2013 New trial record